Rehmannioside A improves cognitive impairment and alleviates ferroptosis via activating PI3K/AKT/Nrf2 and SLC7A11/GPX4 signaling pathway after ischemia
Year: 2022
Type: article
Source: Journal of Ethnopharmacology
Language: English
Subfield: Neurology
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4210364322
